Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Submitted by
admin
on December 4, 2017 - 11:39am
Source:
Fierce Pharma
News Tags:
Novartis
generics
Sandoz
M&A
Headline:
Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Do Not Allow Advertisers to Use My Personal information
